United StatesThyroid Tablets, USP, 1/2 Grain (30 mg) (each tablet: levothyroxine 19 mcg, liothyronine 4.5 mcg), 100‑tablet prescription bottles distributed by Vitruvias Therapeutics, Auburn, AL (NDC 69680‑166‑00), Lot #504950, exp. 09/30/2026 (1,955 bottles), sold nationwide in the US, are affected. They were recalled because they are a superpotent drug.
What's being recalled
Thyroid Tablets, USP, 1/2 Grain (30 mg), Each tablet contains: levothyroxine (T4) 19 mcg, liothyronine (T3) 4.5 mcg, 100 Tablets, Rx only, Distributed by: Vitruvias Therapeutics, Auburn, AL 36830, Product of USA, NDC 69680-166-00.
Recalling firm: Vitruvias Therapeutics Inc, Auburn, AL, United States.
How to identify it
Lot # 504950, Exp Date: 09/30/2026.
The hazard
Superpotent Drug
What to do
Don't stop taking a prescribed medicine without talking to your doctor or pharmacist first. For other products, stop using them and ask the pharmacist, seller or maker what to do.
The notice doesn't give instructions for consumers, so this is general advice for health & beauty recalls. Check the official notice for the details.
Where it was sold
US Nationwide.
The official notice
This page is a summary of the notice published by U.S. Food and Drug Administration (enforcement reports), collected from U.S. Food and Drug Administration (enforcement reports). Check the original before you act on it.
Read the official notice (opens in a new tab)